Fredric N. Eshelman, Director, 10% Owner at Furiex Pharmaceuticals, Inc. (FURX), bought 120,394 shares at $20.06 ($2.4M) on 2012-05-31, disclosed to the SEC on 2012-06-04.
Open-market purchase of $2.4M FURX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.06 | 70,075 | $1.4M | 58.6% |
| 2 | $19.72 | 50,319 | $992K | 41.4% |
| Total | $19.92 avg | 120,394 | $2.4M | 100% |
| Filing → |
| LQDA | SELL | 2021-01-21 | $872K | — | Filing → |
| LQDA | SELL | 2021-01-19 | $81K | — | Filing → |
| LQDA | SELL | 2021-01-15 | $219K | — | Filing → |